News about Market

Novartis agrees to acquire Avidity Biosciences

Novartis has announced a definitive agreement to acquire Avidity Biosciences, a move aimed at expanding its neuroscience portfolio with advanced programs targeting rare genetic neuromuscular disorders.

Market | 27/10/2025 | By Dineshwori |  389

Alkermes Enters Sleep Medicine Arena with USD 2.1 Billion Acquisition of Avadel

Alkermes plc has announced it will acquire Avadel Pharmaceuticals in a deal valued at up to USD 2.1 billion, marking the company’s strategic entry into the sleep medicine market.

Market | 24/10/2025 | By Darshana |  252

Lupin Launches Generic Version of Ravicti in the US

Global pharma major Lupin has launched an authorised generic version of Ravicti (Glycerol Phenylbutyrate) Oral Liquid, 1.1g/mL, in the United States.

Market | 24/10/2025 | By Dineshwori |  276

Biocon Biologics and Civica Launch Private-Label Insulin Glargine in the US

The multi-year transformational agreement between Biocon Biologics and Civica creates an exclusive distributorship arrangement where Biocon Biologics will manufacture and supply Insulin Glargine medicine to Civica, and Civica will commercialise under Biocon Biologics’ existing marketing approval.

Market | 21/10/2025 | By Dineshwori |  338

Pelage Pharma Raises USD 120 Million to Advance Regenerative Hair Loss Therapy

Pelage Pharmaceuticals, a Los Angeles-based clinical-stage regenerative medicine company, has raised USD 120 million in a Series B funding round to accelerate the development of its innovative treatment for hair loss. The financing was co-led by ARCH Venture Partners and GV (formerly Google Ventures), with participation from existing investors.

Market | 17/10/2025 | By Darshana |  269

Sunshine Biopharma's Canadian subsidiary Nora Pharma Launches Generic Cholesterol Drug Pravastatin

Sunshine Biopharma’s wholly owned Canadian subsidiary, Nora Pharma, has launched Pravastatin, a generic prescription drug in the therapeutic class of Lipid Metabolism Regulators.

Market | 17/10/2025 | By Dineshwori |  336

Rubicon Research Listed on NSE

Mumbai-based pharmaceutical formulations company Rubicon Research Ltd has been officially listed on the National Stock Exchange (NSE).

Market | 16/10/2025 | By Dineshwori |  509

India's Drugs & Pharmaceuticals Exports Continue Upward Trend in September 2025

India’s drugs and pharmaceuticals exports rose by 2.56 percent, reaching USD 2.62 billion in September 2025, up from USD 2.56 billion in the same month last year, according to the latest data from the Ministry of Commerce & Industry.

Market | 16/10/2025 | By Dineshwori |  1349

Syngene International Invests in Peptide Laboratory and Advanced Automation

Syngene International has set up a dedicated peptide laboratory equipped with advanced automation technologies to accelerate hit-to-lead timelines. The investment enhances the company’s integrated drug discovery and development capabilities, reinforcing its position as a leading partner for end-to-end research solutions.

Market | 16/10/2025 | By Dineshwori |  432

AstraZeneca India to Launch Hyperkalaemia Treatment Lokelma in November 2025

AstraZeneca Pharma India Limited (AZPIL) has announced the upcoming launch of Sodium Zirconium Cyclosilicate powder for oral suspension 5g (Lokelma) in India in November 2025.

Market | 15/10/2025 | By Dineshwori |  1258